Moloney Securities Asset Management, LLC Abb Vie Inc. Transaction History

Moloney Securities Asset Management, LLC

$664 Million
Q1 2025

A detailed history of Moloney Securities Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 12,784 shares of ABBV stock, worth $2.44 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

12,784

Previous 22,080 42.1%

Holding current value

$2.44 Million

Previous $3.92 Million 31.74%

% of portfolio

0.4%

Previous 0.56%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$169.2 - $216.66 $1.57 Million - $2.01 Million	-9,296 Reduced 42.1%	12,784 $2.68 Million
Q4 2024 Jan 28, 2025	SELL	$164.99 - $203.87 $43,722 - $54,025	-265 Reduced 1.19%	22,080 $3.92 Million
Q3 2024 Oct 30, 2024	BUY	$163.84 - $199.33 $90,767 - $110,428	554 Added 2.54%	22,345 $4.41 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $473,812 - $553,306	-3,061 Reduced 12.32%	21,791 $3.74 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $268,177 - $305,563	-1,678 Reduced 6.32%	24,852 $4.53 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $163,606 - $184,259	-1,189 Reduced 4.29%	26,530 $4.11 Million
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $1,068 - $1,237	8 Added 0.03%	27,719 $4.13 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $90,901 - $113,121	686 Added 2.54%	27,711 $3.73 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $747,633 - $861,011	-5,170 Reduced 16.06%	27,025 $4.31 Million
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $41,354 - $49,595	-299 Reduced 0.92%	32,195 $5.21 Million
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $139,578 - $160,087	-1,040 Reduced 3.1%	32,494 $4.36 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $8,945 - $11,372	-65 Reduced 0.19%	33,534 $5.14 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $13,461 - $16,702	102 Added 0.3%	33,599 $5.45 Million
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $14,717 - $18,622	-137 Reduced 0.41%	33,497 $4.54 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $115,231 - $130,804	1,083 Added 3.33%	33,634 $3.63 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $472,392 - $526,272	4,490 Added 16.0%	32,551 $3.67 Million
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $525,105 - $578,078	-5,133 Reduced 15.46%	28,061 $3.04 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $36,381 - $49,118	-452 Reduced 1.34%	33,194 $3.56 Million
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $27,147 - $31,862	-316 Reduced 0.93%	33,646 $2.95 Million
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $10,125 - $13,548	-138 Reduced 0.4%	33,962 $3.33 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $214,527 - $325,249	3,326 Added 10.81%	34,100 $2.6 Million
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $16,157 - $20,216	-224 Reduced 0.72%	30,774 $2.73 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $17,886 - $21,504	284 Added 0.92%	30,998 $2.35 Million
Q2 2019 Jul 29, 2019	SELL	$65.7 - $83.98 $26,871 - $34,347	-409 Reduced 1.31%	30,714 $2.23 Million
Q1 2019 May 03, 2019	BUY	$77.14 - $90.79 $226,328 - $266,377	2,934 Added 10.41%	31,123 $2.51 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $225,142 - $277,660	-2,892 Reduced 9.3%	28,189 $2.6 Million
Q3 2018 Oct 24, 2018	BUY	$88.91 - $98.84 $34,763 - $38,646	391 Added 1.27%	31,081 $0
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $125,243 - $148,190	1,395 Added 4.76%	30,690 $2.84 Million
Q1 2018 Apr 25, 2018	SELL	$92.01 - $123.21 $149,976 - $200,832	-1,630 Reduced 5.27%	29,295 $2.77 Million
Q4 2017 Jan 25, 2018	SELL	$89.56 - $98.21 $372,838 - $408,848	-4,163 Reduced 11.86%	30,925 $2.99 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $2.45 Million - $3.13 Million	35,088	35,088 $3.12 Million

Others Institutions Holding ABBV

# of Institutions

4,251

Shares Held

1.27B

Call Options Held

16.5M

Put Options Held

14.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $338B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Account

Moloney Securities Asset Management, LLC Abb Vie Inc. Transaction History